Related Experiment Videos
MiR-1281 downregulates LMX1B to inhibit gastric cancer development
Shenshuo Gao1, Jinqiu Xiong1, Xuguang Jiao1
1Medical Center for Gastrointestinal Surgery, Weifang People's Hospital, Shandong Second Medical University, Weifang, Shandong Province, 261041, China.
Abstract:
Gastric cancer (GC) is a prevalent and life-threatening malignancy worldwide, with its complex pathogenesis remaining incompletely understood. Identifying novel molecular mechanisms underlying gastric cancer development is crucial for improving diagnosis and treatment strategies. In this study, we investigated the role of miR-1281 and its target gene LMX1B in gastric cancer progression. We employed a series of experimental techniques, including real-time quantitative polymerase chain reaction (RT-qPCR) to measure the expression levels of miR-1281 in gastric cancer cell lines and clinical tissue samples. Luciferase reporter assays were performed to validate the direct binding between miR - 1281 and the 3'-untranslated region (3'-UTR) of LMX1B mRNA. Functional assays such as cell proliferation, invasion and migration assays were carried out to evaluate the effects of miR-1281 and LMX1B on gastric cancer cell behaviors. The results showed that miR-1281 was significantly downregulated in gastric cancer tissues and cell lines compared with normal counterparts. Overexpression of miR-1281 remarkably inhibited gastric cancer cell proliferation, invasion and migration. Mechanistically, we demonstrated that miR-1281 directly targeted the 3'-UTR of LMX1B mRNA, leading to decreased LMX1B expression. Conversely, knockdown of LMX1B phenocopied the effects of miR-1281 overexpression, while restoration of LMX1B expression reversed the inhibitory effects of miR-1281 on gastric cancer cells. In addition, clinical correlation analysis revealed that low miR-1281 expression was associated with poor prognosis in gastric cancer patients, while high LMX1B expression showed an opposite correlation. In conclusion, our findings suggest that miR-1281 functions as a tumor suppressor in gastric cancer by downregulating LMX1B expression. The miR - 1281/LMX1B axis may serve as a potential therapeutic target and prognostic biomarker for gastric cancer, providing new insights into the molecular mechanisms of gastric cancer development and offering novel strategies for its treatment.
Insights
MicroRNA-1281 (miR-1281) acts as a tumor suppressor in gastric cancer by inhibiting the LMX1B gene. This discovery offers potential new diagnostic and therapeutic strategies for gastric cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer (GC) is a leading cause of cancer-related mortality globally.
- Understanding the molecular mechanisms of GC is critical for developing effective treatments.
Purpose of the Study:
- To investigate the role of miR-1281 and its target gene LMX1B in gastric cancer progression.
- To explore the potential of the miR-1281/LMX1B axis as a therapeutic target and prognostic biomarker.
Main Methods:
- Real-time quantitative polymerase chain reaction (RT-qPCR) for expression analysis.
- Luciferase reporter assays to confirm direct targeting.
- Functional assays (proliferation, invasion, migration) to assess cellular effects.
- Clinical correlation analysis.
Main Results:
- miR-1281 was significantly downregulated in gastric cancer tissues and cell lines.
- Overexpression of miR-1281 inhibited GC cell proliferation, invasion, and migration.
- miR-1281 directly targets LMX1B, reducing its expression.
- Low miR-1281 and high LMX1B expression correlated with poor patient prognosis.
Conclusions:
- miR-1281 functions as a tumor suppressor in gastric cancer by downregulating LMX1B.
- The miR-1281/LMX1B pathway represents a promising therapeutic target and prognostic biomarker for GC.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs